Evaluation of the Effects of Systemic Vibration Therapy on Thermogenesis, Cardiovascular Paramete… (NCT07729215) | Clinical Trial Compass
CompletedNot Applicable
Evaluation of the Effects of Systemic Vibration Therapy on Thermogenesis, Cardiovascular Parameters, Endocrine-inflammatory Markers, and Physical-functional Performance in Adults With Obesity.
Brazil90 participantsStarted 2024-10-31
Plain-language summary
The goal of this clinical trial was to evaluate the effects of Systemic Vibration Therapy (SVT) on thermogenesis, cardiovascular health, endocrine-inflammatory markers, and physical performance in adults (men and women, aged 18-59) with obesity. The main questions it aimed to answer were:
What were the effects of SVT on thermogenesis and physical-functional performance in people with obesity?
How did SVT affect cardiovascular risk, hormone levels, and inflammation?
Researchers compared two types of vibrating platforms (vertical and side-alternating) to a placebo group (where the platform was turned off but simulated the sound) to see if the vibration led to changes in these health parameters.
Participants:
Attended sessions 2 times per week for either 6 or 12 weeks.
Stood barefoot in a static squat position on a vibrating platform for 29 minutes per session (alternating 1 minute of vibration with 1 minute of rest).
Underwent health assessments, including blood tests, body composition scans, muscle strength tests, and quality of life questionnaires.
Who can participate
Age range
18 Years – 59 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Individuals aged 18 to 59 years;
* Both sexes;
* Diagnosis of obesity, defined as a body mass index (BMI) ≥ 30 kg/m²;
* Waist-to-height ratio (≥ 0.50).
Exclusion Criteria:
* Presence of metallic prostheses;
* Presence of a pacemaker;
* Uncontrolled and untreated hypertension (≥180/120 mmHg);
* History of labyrinthitis;
* Previous diagnosis of deep vein thrombosis;
* Pregnancy;
* Recent surgery (within the previous 6 months);
* Neurodegenerative, pulmonary, or infectious diseases;
* Inability to undergo the proposed assessments and/or interventions.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Thermogenin
Timeframe: Baseline, Week 6, and Week 12
2
Endocrine-inflammatory profile
Timeframe: Baseline, Week 6, and Week 12
Trial details
NCT IDNCT07729215
SponsorLaboratorio de Vibraçoes Mecanicas e Praticas Integrativas